ALMOTRIPTAN MALATE Drug Patent Profile
✉ Email this page to a colleague
When do Almotriptan Malate patents expire, and what generic alternatives are available?
Almotriptan Malate is a drug marketed by Ajanta Pharma Ltd, Mylan, and Teva Pharms Usa. and is included in three NDAs.
The generic ingredient in ALMOTRIPTAN MALATE is almotriptan malate. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Almotriptan Malate
A generic version of ALMOTRIPTAN MALATE was approved as almotriptan malate by TEVA PHARMS USA on July 7th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALMOTRIPTAN MALATE?
- What are the global sales for ALMOTRIPTAN MALATE?
- What is Average Wholesale Price for ALMOTRIPTAN MALATE?
Summary for ALMOTRIPTAN MALATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 5 |
| Patent Applications: | 388 |
| Drug Prices: | Drug price information for ALMOTRIPTAN MALATE |
| DailyMed Link: | ALMOTRIPTAN MALATE at DailyMed |
Recent Clinical Trials for ALMOTRIPTAN MALATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Janssen-Ortho LLC | Phase 4 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 4 |
| Ortho-McNeil Neurologics, Inc. | Phase 4 |
Pharmacology for ALMOTRIPTAN MALATE
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ALMOTRIPTAN MALATE
Paragraph IV (Patent) Challenges for ALMOTRIPTAN MALATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| AXERT | Tablets | almotriptan malate | 6.25 mg and 12.5 mg | 021001 | 1 | 2005-12-08 |
US Patents and Regulatory Information for ALMOTRIPTAN MALATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | ALMOTRIPTAN MALATE | almotriptan malate | TABLET;ORAL | 205523-001 | Mar 3, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | ALMOTRIPTAN MALATE | almotriptan malate | TABLET;ORAL | 205171-002 | Nov 9, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ajanta Pharma Ltd | ALMOTRIPTAN MALATE | almotriptan malate | TABLET;ORAL | 205523-002 | Mar 3, 2016 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | ALMOTRIPTAN MALATE | almotriptan malate | TABLET;ORAL | 205171-001 | Nov 9, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | ALMOTRIPTAN MALATE | almotriptan malate | TABLET;ORAL | 078027-002 | Jul 7, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
